1613329-98-8

Basic information

• Product Name: (5-chloro-2-methyl-3-nitrophenyl) methanol
• CAS NO: 1613329-98-8
• Molecular Weight: 201.609
• Mol File: 1613329-98-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (5-chloro-2-methyl-3-nitrophenyl) methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (5-chloro-2-methyl-3-nitrophenyl) methanol(1613329-98-8)
• EPA Substance Registry System: (5-chloro-2-methyl-3-nitrophenyl) methanol(1613329-98-8)

Safety Data

• Hazardous Substances Data: 1613329-98-8(Hazardous Substances Data)

Usage

General Description

(5-chloro-2-methyl-3-nitrophenyl) methanol is a chemical compound that is commonly used in the synthesis of pharmaceuticals and agrochemicals. It is a derivative of phenol, which is a widely used precursor in organic synthesis. (5-chloro-2-methyl-3-nitrophenyl) methanol contains a chlorine atom and a nitro group, which are important functional groups in organic chemistry. The presence of a methyl group also makes it a versatile building block for the synthesis of diverse chemical compounds. Additionally, the hydroxyl group in the compound makes it a potential candidate for biological activities. Overall, (5-chloro-2-methyl-3-nitrophenyl) methanol is a valuable chemical with a wide range of applications in various industries, particularly in the pharmaceutical and agrochemical sectors.

Upstream product

• 67-56-1 methanol 
• 154257-81-5 5-chloro-2-methyl-3-nitrobenzoic acid 
• 7499-06-1 5-chloro-2-methylbenzoic acid 

Relevant articles and documents

The bridge ring piperazine derivative or its salt and its preparation and use (by machine translation)

The invention belongs to the technical field of chemical medicine, relates to bridge piperazine derivative or its salt and its preparation method, and the states the bridge arch piperazine derivative or a salt thereof in the preparation in the treatment of diseases associated with the ROR γ t use in the medicament. By experiment, the results display, of the bridge of the present invention can effectively inhibit the piperazine derivatives ROR γ t protein receptor, regulating Th17 cell differentiation, inhibiting IL - 17 production, can be further used to treat ROR γ t-mediated inflammation-related drug for the treatment of such diseases, especially suitable for the treatment of multiple sclerosis, rheumatoid arthritis, collagen induced arthritis, psoriasis, inflammatory bowel disease, encephalomyelitis, cloning disease, asthma, inflammation-related diseases such as cancer. (by machine translation)

Novel compounds

The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

NOVEL COMPOUNDS

Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.